Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative versus postoperative esomeprazole for intragastric pH control and bleeding after gastric ESD
ChiCTR-IPR-15007386Phase 4Recruiting
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esomeprazole in gastric cancer (GC) and gastric preneoplasia (2 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoint: Mean percentage of time with intragastric pH > 4 during 24-hour monitoring on day 1 after ESD. Started Oct 2015; status: recruiting.
02
Drugs
esomeprazole
03
Conditions
gastric cancer (GC)gastric preneoplasia
Beyond the preview
Go deeper on ChiCTR-IPR-15007386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007386.